Zingiber officinale extract exhibits antidiabetic potential via modulating glucose uptake, protein glycation and inhibiting adipocyte differentiation: An in vitro study

Journal of the Science of Food and Agriculture

Volumn 92, Issue 9, 2012, Pages 1948-1955

  Rani, M Priya ^a   Krishna, Mahesh S ^a   Padmakumari, Keezheveettil P ^a   Raghu, K Gopal ^a   Sundaresan, Andikannu ^a  

^a REGIONAL RESEARCH LABORATORY CSIR   (India)

Author keywords

Adipocyte differentiation; Flow cytometry; Glut 4; HPLC; L6 mouse myoblasts

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2,2-DIPHENYL-1-PICRYLHYDRAZYL; ADVANCED GLYCATION END PRODUCT; ANTIDIABETIC AGENT; ANTIOXIDANT; BIPHENYL DERIVATIVE; CATECHOL DERIVATIVE; FATTY ALCOHOL; GINGEROL; GLUCOSE; GLUCOSE TRANSPORTER 4; PICRIC ACID; PLANT EXTRACT; PROTEIN; SHOGAOL;

ADIPOCYTE; ADIPOGENESIS; ANIMAL; ARTICLE; CELL MEMBRANE; CHEMISTRY; CYTOLOGY; DIABETES MELLITUS; DRUG ANTAGONISM; DRUG EFFECT; GINGER; METABOLISM; MOUSE; MYOBLAST; PHYTOTHERAPY; RHIZOME; SKELETAL MUSCLE; TRANSPORT AT THE CELLULAR LEVEL;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTIOXIDANTS; BIOLOGICAL TRANSPORT; BIPHENYL COMPOUNDS; CATECHOLS; CELL MEMBRANE; DIABETES MELLITUS; FATTY ALCOHOLS; GINGER; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPOGLYCEMIC AGENTS; MICE; MUSCLE FIBERS, SKELETAL; MYOBLASTS; PHYTOTHERAPY; PICRATES; PLANT EXTRACTS; PROTEINS; RHIZOME;

ZINGIBER OFFICINALE; ZINGIBERACEAE;

EID: 84861968349     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.5567     Document Type: Article

References (21)

1. Nathan DM, Long-term complications of diabetes mellitus. N Engl J Med 328: 1676-1685 (1993).
2. Rehman R, Akram M, Naveed A, Qaiser J, Tariq S and Ali Shah, Zingiber officinale Roscoe (pharmacological activity). J Med Plants Res 5: 344-348 (2011).
3. Bhandari U, Kanojia R and Pillai KK, Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 97: 227-230 (2005).
4. Noipha K, Ratanachaiyavong S and Ninla-aesong P, Enhancement of glucose transport by selected plant foods in muscle cell line L6. Diabetes Res Clin Pract 89: E22-E26 (2010).
5. Priya Rani M, Padmakumari KP, Sankarikutty B, Lijo Cherian O, Nisha VM and Raghu KG, Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. Int J Food Sci Nutr 62: 106-110 (2011).
6. Badreldin HA, Gerald B, Musbah O and Abderrahim N, Some phyto-chemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem Toxicol 46: 409-420 (2008).
7. Brand-Williams W, Cuvelier ME and Berset C, Use of free radical method to evaluate antioxidant activity. Lebensm-Wiss Technol 28: 25-30 (1995).
8. Kotamballi N, Chidambara M, Ravendra PS and Jayaprakasha KG, Antioxidant activities of grape (Vitis vinifera) pomace extracts. J Agric Food Chem 50: 5909-5914 (2002).
9. Wilson AP, Cytotoxicity and viability assays, in Animal Cell Culture: A Practical Approach, 2nd edition, ed. by Masters JRW. Oxford University Press, Oxford, pp. 175-219 (2000).
10. Chen QC, Zhang WY, Jin W, Lee IS, Min BS and Jung HJ, Flavonoids and isoflavonoids from Sophorae flos improve glucose uptake in vitro. Planta Med 76: 79-81 (2010).
11. Maldie D, Adipose tissue protocols, in Methods in Molecular Biology, 5th edition, ed. by Ailhaud G. Humana Press, New Jersey, pp. 54-56 (2008).
12. Arom J, In vitro antiglycation activity of arbutin. Naresuan Univ J 13: 35-41 (2005).
13. Blanca HL, Pedro JMA and Encarnacion P, Assessment of the spec-trometric method for determination of angiotensin-converting enzyme activity: Influence of the inhibition type. J Agric Food Chem 51: 4175-4179 (2003).
14. Kim JK, Kim Y, Na KM, Surh YJ and Kim TY, Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Radical Res 41: 603-614 (2007).
15. Halliwell B, How to characterize a biological antioxidant. Free Radical Res Commun 9: 1-32 (1990).
16. Mitsumoto Y and Klip A, Developmental regulation of the subcellular distribution and glycosylation of GLUT 1 and GLUT 4 glucose transporters during myogenesis of L6 muscle cells. J Biol Chem 267: 4957-4962 (1992).
17. Henriksen EJ, Bourey RE, Rodnick KJ, Koranyi L, Permutt MA and Holloszy JO, Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am J Physiol 259: E593-E598 (1990).
18. Skeggs LT, Kahn JR and Shumway NP, The preparation and function of the hypertensin-converting enzyme. J Exp Med 103: 295-299 (1956).
19. Oh H, Kang DG, Lee S and Lee HS, Angiotensin converting enzyme inhibitors from Cusuta japonica choisy. J Ethnopharmacol 83: 105-108 (2002).
20. Wagner H, Elbi G, Lotter H and Guinea M, Evaluation of natural products as inhibitors of angiotensin 1-converting enzyme (ACE). Pharm Pharmacol Lett 1: 15-18 (1991).
21. Hansen K, Nyman U, Smitt UW, Anne A, Gudiksen L and Rajasekharan S, In-vitro screening of traditional medicines for antihypertensive effect based on inhibition of the angiotensin converting enzyme. J Ethnopharmacol 48: 43-51 (1995).